UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058319
Receipt number R000066674
Scientific Title A Prospective Observational Study to Evaluate the Safety and Usefulness of Head-up Endoscopic Examination
Date of disclosure of the study information 2025/06/30
Last modified on 2025/06/30 14:47:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective Observational Study on Head-up Endoscopic Examination

Acronym

Study on Head-up Endoscopic Examination

Scientific Title

A Prospective Observational Study to Evaluate the Safety and Usefulness of Head-up Endoscopic Examination

Scientific Title:Acronym

Prospective Observational Study on Head-up Endoscopic Examination

Region

Japan


Condition

Condition

Upper Gastrointestinal Diseases

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the safety and outcomes of head-up endoscopic examination, including their association with background factors and endoscopic findings, with the expectation of contributing to the establishment of further diagnostic methods and treatment strategies for diseases.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of complications due to endoscopic examination

Key secondary outcomes

Participant background (demographic information, medical history), physical findings (vitals, height/weight, adverse event confirmation, concomitant medication confirmation), clinical laboratory tests (hematological tests, blood biochemical tests), endoscopic findings, radiological examinations (CT), pathological findings, severity of complications (perforation, bleeding, stricture), presence/absence of additional treatment, medical expenses


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who visit Keio University Hospital outpatient clinic for upper gastrointestinal endoscopy between the research implementation approval date and April 2030, and who provide free-willed informed consent for this study.

Key exclusion criteria

1 Cases with severe heart disease, 2 Minors or cases lacking capacity to consent due to dementia etc., 3 Other cases judged unsuitable for registration by the attending physician, 4 Cases where the research participant refuses to participate in this study after registration.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Mari
Middle name
Last name Mizutani

Organization

Keio University

Division name

Endoscopy-center

Zip code

160-8582

Address

35, Shinanomachi, Shinjyuku-ku, Tokyo, Japan

TEL

03-3353-1211

Email

marimizutani6@keio.jp


Public contact

Name of contact person

1st name Mari
Middle name
Last name Mizutani

Organization

Keio University

Division name

Endoscopy-Center

Zip code

160-8582

Address

35, Shinanomachi, Shinjyuku-ku, Tokyo, Japan

TEL

03-3353-1211

Homepage URL


Email

marimizutani6@keio.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

Keio University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University

Address

35, Shinanomachi, Shinjyuku-ku, Tokyo, Japan

Tel

03-3353-1211

Email

n/a


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 06 Month 30 Day

Date of IRB


Anticipated trial start date

2025 Year 07 Month 01 Day

Last follow-up date

2035 Year 07 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The safety of head-up endoscopic examination (incidence of complications) will be the primary outcome, and the association with background factors, endoscopic findings, severity of complications, and medical expenses will be investigated as secondary outcomes


Management information

Registered date

2025 Year 06 Month 30 Day

Last modified on

2025 Year 06 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066674